NYSE$ZTS

Zoetis · Q3 2021 earnings

Q3 2021 earnings · · Investor relations

Briefing

Reported revenue growth of 11% and net income increase of 15% for the third quarter of 2021.

Zoetis reported strong Q3 2021 results with revenue of $2.0 billion, an 11% increase compared to Q3 2020. Net income was $552 million, a 15% increase. Adjusted net income was $597 million, a 14% increase. The company has increased its full year 2021 revenue guidance to $7.700 - $7.750 billion and diluted EPS of $4.23 - $4.29 on a reported basis, or $4.62 - $4.67 on an adjusted basis.

  • Revenue reached $2.0 billion, reflecting an 11% increase.
  • Net income amounted to $552 million, with a diluted EPS of $1.16, marking a 15% and 16% increase, respectively.
  • Adjusted net income stood at $597 million, resulting in an adjusted diluted EPS of $1.25.
  • Operational revenue and adjusted net income both grew by 10%.

Headline financials

Total Revenue

$1.99B

Previous: $1.79B+11.4%
EPS (adj)

$1.25

Previous: $1.10+13.6%
Companion Animal Growth

21.0%

Previous: 20.0%+5.0%
Livestock Growth

0.0%

Previous: 9.0%-100.0%
U.S. Revenue Growth

7.0%

Previous: 18.0%-61.1%
International Revenue Growth

18.0%

Previous: 11.0%+63.6%
Capital Expenditures

-$309M

Previous: -$301M-2.7%
Free Cash Flow

$243M

Previous: $178M+36.5%
Net Income

$552M

Previous: $479M+15.2%
Operating Income

$665M

Previous: $629M+5.7%
Gross Profit

$1.4B

Previous: $1.24B+13.2%
Cash & Equivalents

$3.27B

Previous: $3.65B-10.4%
Total Assets

$13.7B

Previous: $13.7B-0.1%
Stock-Based Comp

$15M

Previous: $14M+7.1%

Revenue & EPS history

Zoetis · Revenue · Quarterly

$1.99B

Q3 2021+11.4%vs Q3 2020
Beat estimate in 16 of 16 quarters(100%)
ActualEstimate

Revenue by segment

Zoetis · $1.99B total across 3 segments · Q3 2021

  • Companion Animal
    $1.2B+20.8%
  • Livestock
    $767M-0.1%
  • Contract Mfg & Human Health
    $21M-8.7%

Forward guidance

Zoetis is increasing its full year 2021 guidance, which includes revenue between $7.700 billion and $7.750 billion, reported diluted EPS between $4.23 and $4.29, and adjusted diluted EPS between $4.62 and $4.67.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2021

Historical avgQ3 2021

+0.4%

Avg return

Earnings day

-0.6%

Avg return

5 days after

+0.5%

Avg return

30 days after

55%

32 / 58 earnings

Positive

+8.1%

Q4 2018

Best reaction

-13.7%

Q3 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.2%-30.9%-28.5%
Q4 2025-2.4%-2.4%-10.1%
Q3 2025-13.7%-16.7%-16.6%
Q2 2025-3.7%-2.9%+0.9%
Q1 2025-5.3%+0.8%+6.7%
Q4 2024-5.1%-10.0%-7.3%
Q3 2024-3.7%-2.8%-3.6%
Q2 2024+5.7%+6.0%+6.7%
Q1 2024+5.4%+6.3%+7.0%
Q4 2023-6.4%-4.2%-11.6%
Q3 2023+7.1%+10.4%+18.3%
Q2 2023+4.8%+5.6%+3.9%
Q1 2023+4.8%+3.7%-3.3%
Q4 2022+7.3%+5.4%+1.9%
Q3 2022-9.3%-7.6%+6.8%
Q2 2022-3.1%-5.9%-12.9%
Q1 2022-4.3%-8.0%-4.4%
Q4 2021-0.7%-2.6%-1.4%
Q3 2021+2.7%+4.3%+5.8%
Q2 2021-1.4%-2.9%+2.4%
Q1 2021-1.3%-2.1%+0.8%
Q4 2020+1.3%-4.0%-8.6%
Q3 2020-2.9%-6.8%-9.4%
Q2 2020+0.7%-0.5%-0.3%
Q1 2020-5.4%-3.7%+7.4%
Q4 2019+0.8%+0.5%-12.2%
Q3 2019-3.0%-3.5%+0.2%
Q2 2019+7.4%+11.1%+13.8%
Q1 2019+1.9%-0.4%-0.7%
Q4 2018+8.1%+7.5%+9.8%
Q3 2018+2.9%+2.9%+4.1%
Q2 2018+6.5%+7.5%+5.3%
Q1 2018-3.6%-1.5%+2.4%
Q4 2017+7.1%+7.9%+13.6%
Q3 2017+6.5%+6.1%+12.1%
Q2 2017-1.6%-3.4%+4.9%
Q1 2017+7.0%+6.9%+12.4%
Q4 2016-4.8%-3.0%-2.1%
Q3 2016+3.6%+5.8%+3.9%
Q2 2016+3.4%+2.2%+3.1%
Q1 2016+0.2%
Q4 2015+3.4%
Q3 2015+5.2%
Q2 2015+0.3%
Q1 2015-0.2%
Q4 2014+4.3%
Q3 2014+4.1%
Q2 2014-2.8%
Q1 2014+0.4%
Q4 2011+0.1%
Q4 2013-3.7%
Q3 2012-0.5%
Q3 2013-2.1%
Q2 2012-1.4%
Q2 2013-0.0%
Q1 2012+0.9%
Q4 2012+0.9%
Q1 2013+2.2%
Q3 2011
Q2 2011
Q1 2011

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro